Sarepta price target lowered to $20 from $23 at Piper Sandler
Piper Sandler lowered the firm's price target on Sarepta to $20 from $23 and keeps a Neutral rating on the shares. The firm lowers its Q2 Elevidys U.S. revenue estimate to $93M from $102.9M and collaboration revenue to $40.8M from $50.8M, consistent with management's guidance and Sarepta-compiled consensus.